SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-21-007423
Filing Date
2021-05-18
Accepted
2021-05-18 16:16:15
Documents
13
Period of Report
2021-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp151239_8k.htm   iXBRL 8-K 31025
5 EXHIBIT 99.1 dp151239_ex9901.htm EX-99.1 139285
  Complete submission text file 0000950103-21-007423.txt   368503

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crl-20210518.xsd EX-101.SCH 3169
3 XBRL LABEL FILE crl-20210518_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE crl-20210518_pre.xml EX-101.PRE 22700
6 EXTRACTED XBRL INSTANCE DOCUMENT dp151239_8k_htm.xml XML 3506
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 21936161
SIC: 8731 Services-Commercial Physical & Biological Research